Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Mar 28, 2025 | 11.54 | -3.99 |
Oak Valley Bancorp | OVLY | Mar 28, 2025 | 25.12 | -0.51 |
Oak Woods Acquisition | OAKU | Mar 28, 2025 | 11.56 | 0.00 |
Oaktree Acquisition III Life Sciences | OACC | Mar 28, 2025 | 10.22 | 0.00 |
Oaktree Acquisition III Life Sciences Unit | OACCU | Mar 28, 2025 | 10.33 | +0.19 |
Oaktree Capital A Pref | OAK-A | Mar 28, 2025 | 21.78 | +0.05 |
Oaktree Capital Group B Pref | OAK-B | Mar 28, 2025 | 21.53 | +1.22 |
Oaktree Specialty | OCSL | Mar 28, 2025 | 15.50 | -0.70 |
Oatly ADR | OTLY | Mar 28, 2025 | 9.90 | +0.30 |
Oblong | OBLG | Mar 28, 2025 | 3.49 | +0.81 |
Occidental Petroleum | OXY | Mar 28, 2025 | 48.83 | -1.37 |
Ocean Biomedical | OCEA | Mar 28, 2025 | 0.06 | -18.46 |
Ocean Power Technologies | OPTT | Mar 28, 2025 | 0.47 | -1.86 |
Oceaneering International | OII | Mar 28, 2025 | 21.60 | -1.68 |
OceanFirst Financial | OCFC | Mar 28, 2025 | 17.06 | -1.10 |
OceanFirst Pref | OCFCP | Mar 28, 2025 | 25.30 | 0.00 |
OceanPal | OP | Mar 28, 2025 | 0.87 | +0.01 |
Ocugen | OCGN | Mar 28, 2025 | 0.80 | +10.44 |
Ocular Therapeutix | OCUL | Mar 28, 2025 | 7.58 | -2.19 |
Oculis | OCS | Mar 28, 2025 | 19.18 | -1.13 |
Oddity Tech | ODD | Mar 28, 2025 | 42.94 | -1.54 |
Odysight.ai | ODYS | Mar 28, 2025 | 6.80 | 0.00 |
Odyssey Marine Exploration | OMEX | Mar 28, 2025 | 0.41 | -4.66 |
Offerpad Solutions A | OPAD | Mar 28, 2025 | 1.70 | -5.56 |
Office Properties | OPI | Mar 28, 2025 | 0.48 | -4.35 |
OFG Bancorp | OFG | Mar 28, 2025 | 40.24 | -1.78 |
OFS Capital | OFS | Mar 28, 2025 | 8.99 | -0.11 |
OFS Credit | OCCI | Mar 28, 2025 | 6.19 | -0.16 |
OFS Credit C Pref | OCCIO | Mar 28, 2025 | 24.70 | 0.00 |
OFS Credit Company Pref F | OCCIM | Mar 28, 2025 | 24.65 | -0.41 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.